NIH Common Fund

NIH Common Fund

NEW! Funding Opportunities in the Illuminating the Druggable Genome (IDG) Program.

• Adaptation of Scalable Technologies to Illuminate the Druggable Genome (U01)
  (RFA-RM-13-010)
• Development of a Knowledge Management Center for Illuminating the Druggable Genome (U54)
  (RFA-RM-13-011)

• Big Data to Knowledge
• Bioinformatics and Computational Biology
• Bridging Interventional Development
  Gaps (BrIDGs)
  (Formerly known as NIH-RAID)
• Building Blocks, Biological Pathways and Networks
• Enhancing the Diversity of the NIH-Funded Workforce
• Epigenomics
• Extracellular RNA Communication
• Genotype-Tissue Expression (GTEx)
• Global Health
• Gulf Oil Spill
• HCS Research Collaboratory
• Health Economics
• High-Risk Research:
  • NIH Director’s Early Independence Award (EIA)
  • NIH Director’s New Innovator Award
  • NIH Director’s Pioneer Award
  • NIH Director’s Transformative Research Awards
• Human Microbiome Project
• Illuminating the Druggable Genome
• Knockout Mouse Phenotyping
• Library of Integrated Network-Based Cellular Signatures (LINCS)
• Metabolomics
• Molecular Libraries and Imaging
• Nanomedicine
• NIH Center for Regenerative Medicine
  (NIH CRM)
• NIH Medical Research Scholars Program
• PROMIS: Patient-Reported Outcomes Measurement Information System
• Protein Capture Reagents
• Regulatory Science
• Science of Behavior Change
• Single Cell Analysis
• Strengthening the Biomedical Research Workforce
• Structural Biology
• Undiagnosed Diseases